FROBEN

This brand name is authorized in Estonia, Japan, Lithuania, South Africa

Active ingredients

The drug FROBEN contains one active pharmaceutical ingredient (API):

1	Flurbiprofen UNII 5GRO578KLP - FLURBIPROFEN
	Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties.
	Read more about Flurbiprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FROBEN Coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1669776, 1669787
JP	医薬品医療機器総合機構	1149011D1032, 1149011F1076
LT	Valstybinė vaistų kontrolės tarnyba	1075073
ZA	Health Products Regulatory Authority	K/3.1/4, K/3.1/5, Q/3.1/260, Q/3.1/338, V/3.1/90